RE: This has been a downward dog for a while13 Jan 2022 19:31
Further thoughts on fredintheshed's post.
On reflection, if the purpose of the announced full strategic review really is to "ensure that the shareholder value is optimised", it could be encouraging. I mean it's exactly the sort of thing a major shareholder or activist investor might insist on and I wouldn't be surprised if that's what's going on behind the scenes here. I can't imagine they'll be providing any further details on Tuesday, if the review has just started.
Per the update, the board seem v confident they can pass on the cost increases (and quickly). I believe them. Leaving aside stocking/de-stocking, demand is reliable and alternative suppliers will be facing their own margin issues.
I feel better about Accrol than I did yesterday... and that's despite today's further drop. Although I've invested more than I should've, I might shove some more into this share. Possible recovery situation.